The clinical utility of pharmacometric models
- PMID: 29637580
- PMCID: PMC6005593
- DOI: 10.1111/bcp.13603
The clinical utility of pharmacometric models
References
-
- Sheiner LB. Learning versus confirming in clinical drug development. Clin Pharmacol Ther 1997; 61: 275–291. - PubMed
-
- Wajima T, Isbister GK, Duffull SB. A comprehensive model for the humoral coagulation network in humans. Clin Pharmacol Ther 2009; 86: 290–298. - PubMed
-
- Gulati A, Isbister GK, Duffull SB. Effect of Australian elapid venoms on blood coagulation: Australian Snakebite Project (ASP‐17). Toxicon 2013; 61: 94–104. - PubMed
-
- Holford N, Ma SC, Ploeger BA. Clinical trial simulation: a review. Clin Pharmacol Ther 2010; 88: 166–182. - PubMed
-
- Wang Y, Bhattaram AV, Jadhav PR, Lesko LJ, Madabushi R, Powell JR, et al Leveraging prior quantitative knowledge to guide drug development decisions and regulatory science recommendations: impact of FDA pharmacometrics during 2004‐2006. J Clin Pharmacol 2008; 48: 146–156. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
